Eduardo castillo

M.D General Practitioner.

[MCW Vascular and Endovascular Surgery @MCWVascSurg]

This is actually all from one aorta. Better out than in. Type Ia perigrqft flow. Out with the old, in with the older…
#inthebucket
#aortaed
#aorta

[Eduardo castillo @mdvasculared]

@MCWVascSurg Wow! Great case. Difficult decisions. Infected?

[Eduardo castillo @mdvasculared]

@juliachenmd Wow! Congrats 🎉

[Eduardo castillo @mdvasculared]

@numeral767 Buenas. Quisiera saber estado de vía Cajamarca-ibagué. Gracias

[Eduardo castillo @mdvasculared]

@numeral767 @MaciaSinS Buenos días. Quisiera saber el estado y el flujo vehicular en el alto de letras y mariquita? Muchas gracias

[European Society of Vascular Medicine @ESVM_]

Optimal management of asymptomatic carotid
stenosis in 2021: the jury is still out. An international,
multispecialty, expert review and position statement
#VascularMedicine
DOI: 10.23736/S0392-9590.21.04825-2

[Christian Heiss @heissheissheiss]

Revascularisation is important but not everything for PAD: Management of chronic PAD patients with indication for endovascular revascularization - A position paper by ESVM
@ESVM_ @JillBelch @MarianneBrodma1 #VascularMedicine @AngiologieCHUV
https://t.co/fdXHoUK2hY

[Trisha L. Roy MD PhD FACS @trisharoymd]

Every angioplasty causes dissections. We are happy w luminal gain and dismiss vessel wall damage. Can vessel prep help? Our early histologic results of orbital atherectomy is encouraging but bottom line: we need more histologic data! @DeBakeyCVedu

[European Society of Vascular Medicine @ESVM_]

Novel cardiovascular biomarkers associated with peripheral arterial disease in men screened for abdominal aortic aneurysm. Interesting novel bio markers detected, but need more research #PAD #VascularMedicine https://t.co/mrI2BTs7kc

[Leigh Ann O'Banion @limbsalvagedr]

Interesting take...would love to hear what #VascTwitter has to say @gregamagee @Sharon_Kiang_MD @trasmussen_md @gregamagee @ReidRavin @AmputationSuck @farkomd @dskauvar @DrKimberlyMalka @ShereneShalhub @AfifiRana @DejahJudelson @leith_erica @mattsmeds

[Eduardo castillo @mdvasculared]

@KprasMD @drochohan @keithppereira @CHICKVIR @kmadass @Drshiloh @SIRRFS @drgauravgangwni @ShahmanMD @edepopMD Brilliant. You don't even see hyperpigmentation. great technique, great results. What do you use for sclero? varithena or polidocanol with tessari technique? Great work. Congrats 👏🏻

[Eduardo castillo @mdvasculared]

@DanHan @MSHSSurgery wow. how exciting it must be to learn there. As an aspiring and passionate vascular surgeon it is inspiring to see so many ways to train in the field. I hope to reach that goal. Congratulations 👏🏻

[Elsevier for Medical Professionals @Elsevier_Med]

"[We] have focused our energy on maintaining the highest quality of coverage of the field, while improving the presentation and value for the readership in the 10th edition through a very contemporary approach." - Bruce A. Perler, MD, MBA https://t.co/v9IrCjsE9Y

[Eduardo castillo @mdvasculared]

@OHSUvascular @TzeWoeiTan Great news. It is exciting to see the number of integrated vascular surgery programs increase. For those of us who are passionate about vascular surgery and aspire to enter an integrated residency, it is very exciting. big steps. Congrats 👏🏻

[Eduardo castillo @mdvasculared]

Ribaroxaban increasingly involved in PAD. VOYAGE-PAD trial present. It will be interesting to observe the results in the dual management with aspirin after the first 5 years have elapsed. Big steps.

[European Society of Vascular Medicine @ESVM_]

RIVAROXABAN REDUCES HOSPITALIZATIONS FOR THROMBOEMBOLIC EVENTS IN PATIENTS
WITH PERIPHERAL ARTERY DISEASE AFTER REVASCULARIZATION IN THOSE WITH AND WITHOUT
CHRONIC KIDNEY DISEASE
https://t.co/gnQO3B6K12
#VascularMedicine

[European Society of Vascular Medicine @ESVM_]

Impact of Cardiac Function on Loss of Patency in Patients With Peripheral Artery Disease. Cardiac function ie reduced stroke volume & chronic heart failure & smaller distal reference vessel diameter associated with loss of 12-month primary patency in #PAD https://t.co/xxzfGFhNDY

[Ivandito Kuntjoro MD, FACC, FESC, FAMS, FAPSIC @Ditongaje]

Unprovoked PE, intermediate high risk with right heart strain. Right main PA high burden clot. @InariMedical catheter thrombectomy using 24F. PA improved from 30 to 16 post. #nuhcs #pulmonaryembolism #structuralintervention #cardiologist #cardiotwitter

[Eduardo castillo @mdvasculared]

@crzydoc That is one of a thousand reasons to value IMG more Latin Americans in a country with so many Spanish-speaking people. Congrats!!!

[European Society of Vascular Medicine @ESVM_]

Interesting data on venous thrombotic events after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone #PAD https://t.co/6JvjQqbk40

[Gastroenterology Advisor @Gastro_Advisor]

While the presence of inflammatory bowel disease increases the risk for a venous thromboembolic event in affected patients, thrombophilia doesn't play a role in the pathway of increased risk. Study in @JCGjournal #gastroenterology @IBD_GorenMD @Iris_Dotan

https://t.co/UY7082bI40